FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104725 [Registered on: 25/02/2026] Trial Registered Prospectively
Last Modified On: 25/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Ayurvedic Therapies in the management of Primary Hypertension 
Scientific Title of Study   A randomised comparative clinical study to evaluate the efficacy of virechana karma and ksheeradhara in raktagatavata w.s.r hypertension with sarpagandha churna as shamana aushadhi. 
Trial Acronym  No 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sayantan Bera 
Designation  Reader, Department Of Panchakarma 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Dept. of Panchakarma, Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital.
294/3/1 A.P.C Road, Kolkata, West Bengal-700009
Kolkata
WEST BENGAL
700009
India 
Phone  9477150388  
Fax    
Email  dr.sayantanbera@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pallabi Mukherjee 
Designation  Associate Professor and HOD, Department of Kayachikitsa and Panchakarma 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Dept. of Panchakarma, Room No 2 and 4 Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital.
294/3/1 A.P.C Road, Kolkata, West Bengal-700009
Kolkata
WEST BENGAL
700009
India 
Phone  9836362763  
Fax    
Email  dr.tapasbhaduri@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sahil Sk 
Designation  Post graduate trainee 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Dept. of Panchakarma, Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital.
294/3/1 A.P.C Road, Kolkata, West Bengal-700009
Kolkata
WEST BENGAL
700009
India 
Phone  8250462851  
Fax    
Email  sahil0205sk@gmail.com  
 
Source of Monetary or Material Support  
Government of Health and family welfare Swasthyabhawan sectar V GN 29 Saltlake City Kolkata 700091 
 
Primary Sponsor  
Name  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  294/3/1 APC Road, Kolkata 700009 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sahil Sk  Institute of post graduate ayurvedic education and research at SVSP Hospital  Dept. of Panchakarma, Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital. 294/3/1 A.P.C Road, Kolkata, West Bengal-700009
Kolkata
WEST BENGAL 
08250462851

sahil0205sk@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I10||Essential (primary) hypertension. Ayurveda Condition: RAKTAVRUTAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-virecana-karma, विरेचन-कर्म (Procedure Reference: Agnivesha,Caraka samhita ,Vidyotini Hindi commentry by Pgt.kashi natha sastri , Chaukhambha sanskrit sansthan,Varanasi Reprint,2012,Vol-II, Cikitshasthana,CH-28,707P, Procedure details: Virechana karma with Trivit Lehyam. Purva Karma-▪ Deepana -Pachana of the patients will be done by –Panchakola churna – Dose3g. Time of intake- Thrice daily before food. Anupana- Luke warm water. Route of administration- Oral. Duration- According to kostha and agni of patients upto 7-10 days. ▪ Snehapana of patients will be done Sunthi Ghrita / Tila taila. Dose- According to kostha and agni of patients till Samyak Sneha lakshana appears. (max. 7 days). Anupana- Luke warm water. Route of administration- Orally. Time of administrationPradhana Karma- After proper snehana and swedana, Virechana Yoga will be Administered. Trivrit lehyam – Dose- According to patient`s Kostha. Time of intake- Within 9 a.m. -Anupana- Luke warm water. -Route of administration- Oral. Paschyat Karma- Samsarjana Krama will be planned according to the type of shuddhi of the Patient. Follow up-45 days)
(1) Medicine Name: Sarpagandha Churna, Reference: Sastry J.L.N. Illustrated Dravyaguna Vijnana (Study of the Essential medicinal Plants in Ayurveda). Vol II, Reprint Ed. Varanasi: Chaukhambha Orientalia; 2011, 334P, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Duration: 45 Days
2Comparator ArmProcedure-SirobastiH, शिरोबस्तिः (Procedure Reference: Deveaj T.L,The Panchakarma treatment of Ayurveda With Kerala Specialities, Chaukhambha Publisher,Varanasi ,First edition, Revised and Enlarged Delhi2006,106P, Procedure details: Purvakarma: tSelected Patient is adviced to lie down on a Droni ,Proper abyanga done on scalp , forehead,cheek,neck,etc by vatari oil .A cotton thread tied around the head over the eyebrow,eye pad and cotton pad should be placed properly . Pradhana Karma: ksheera (2-3) 4 litre is mildly heated and keep on Dhara patra then it should be pour on the forehead in a specific rhythm along with dhara from one side to another side ,mild massage should be done on the scalp during the process along with dhara. Paschat karma:After completion of ksheeradhara for Stimulated perood cotton pad and cotton thread should be removed and clean the head and adjacent area with a towel soaked in luke warm water.)
(1) Medicine Name: Sarpagandha Churna, Reference: Sastry J.L.N. Illustrated Dravyaguna Vijnana (Study of the Essential medicinal Plants in Ayurveda). Vol II, Reprint Ed. Varanasi: Chaukhambha Orientalia; 2011, 334P, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Duration: 45 Days
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Irrespective of sex, race and religion

Systole Blood Pressure within 140-159 mm of Hg

Diastolic Blood Pressure within 90 to 99 mm Hg

Participants are not taking any hypertensive anti lipidemic medication for 3 months prior to enrollment 
 
ExclusionCriteria 
Details  Patients with cardiac failure, congenital heart diseases, renal failure

Prehypertensive with uncontrolled diabetes

Abuse of alcohol and drugs

Pregnant mother  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1 to reduce Systolic blood pressure from 159 mm of hg to 140 mm of hg
to reduce diastolic blood pressure from 99 of hg to 90 mm of Hg


 
45 days  
 
Secondary Outcome  
Outcome  TimePoints 
to observed the symptoms of pain
any abnormal body temperature
discoloration of skin
any body weight reduction

 
45 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Hypertension is most common lifestyle disorder, It is chronic and often asymptomatic medical condition where BP elevated beyond normal limit.Various Ayurvedic scholar coined different name of Hypertension,Here Raktagatavata is corelated with Hypertension. Hypertension is directly responsible for 57% of all stroke deaths and 24% of all coronary heart dis-ease (CHD) deaths in India. It is the most potent risk factor for diseases of the brain, kidney, heart and peripheral arteries which may prove fatal if not man-aged effectively. Hypertension is a silent killer be-cause most sufferers (85%) are asymptomatic. In 95% of the cases of hypertension, the exact underlying cause is still unknown but is believed to be due to genetic and environmental factors. Hypertension can-not be considered as a Vyadhi (Disease) as per Ayurveda, but it can be understood by assessing the in-volved Doshas, Dooshyas (Entity which is affected by morbid Dosha), Srotas etc. Many Ayurvedic scholars have proposed different theories about how hypertension can be understood in Ayurveda, but there is no standardized and widely accepted view about the Ayurvedic pathogenesis of this condition. Thus, an attempt is made to understand the Samprapti of various types of hypertensions and to find an ideal Chikitsa Sutra ( treatment protocol)2-4 for the management of Raktagatavata.In this Study virechana and ksheeradhara has been applied along with Sarpagandha churna in Raktagatava. In modern medicine there are lots of Complication like, Pedal oedema, left ventricular hypcotrophy, So in Ayurvedic Medicine and therapy there is long lasting effect of over the disease hypertension and no side effects. This is a single centred two arm parallel group with blinded outcome,randomized control trial .Total 60 patient with (30-65) years of age irrespectively of sex , Primary Hypertension (Systolic 140-159 mm of Hg and Diastolic 90- 99 mm of Hg) will be divided into two groups.One on Virechana karma by Trivit Lehyam along with powder sarpagandha, second one ksheeradhara along with powder sarpagandha will be given to the participants.person will be selected strictly on the basis of inclusion and exclusion criteria for this trial programme. 
Close